VB

Vir Biotechnology

VIR
NASDAQHealth Care

Recent Patents

vir
1 year ago

Filed a patent for "cmv-based human papillomavirus vaccines" on Wed, August 2, 2023

New US Patent
vir
1 year ago

Filed a patent for "cmv-based human papillomavirus vaccines" on Wed, April 3, 2024

New US Patent
vir
over 1 year ago

Filed a patent for "methods for producing cmv vectors" on Mon, February 26, 2024

New US Patent
vir
over 1 year ago

Filed a patent for "sulfoximine based stt3a/b modulators for the treatment of disease" on Wed, June 21, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "coronavirus compositions and uses thereof" on Thu, March 2, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "engineered anti-sars-cov-2 antibodies and uses thereof" on Mon, March 6, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "coronavirus compositions and uses thereof" on Fri, March 31, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "antibodies that bind to multiple sarbecoviruses" on Mon, April 10, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "coronavirus compositions and uses thereof" on Mon, October 23, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "antibodies that bind to multiple sarbecoviruses" on Tue, January 30, 2024

New US Patent
vir
over 1 year ago

Filed a patent for "antibodies that bind to multiple sarbecoviruses" on Fri, February 23, 2024

New US Patent
vir
over 1 year ago

Filed a patent for "heterocycle derivatives for the treatment of disease" on Tue, September 27, 2022

New US Patent
vir
over 1 year ago

Filed a patent for "using sparse electronic health records for predicting health outcome" on Mon, November 7, 2022

New US Patent
vir
over 1 year ago

Filed a patent for "high dose antibody therapies for sars-cov-2 infection" on Tue, November 15, 2022

New US Patent
vir
over 1 year ago

Filed a patent for "enpp1 modulators and uses thereof" on Thu, June 15, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "broadly neutralizing antibodies against rsv and mpv paramyxoviruses" on Tue, November 22, 2022

New US Patent
vir
over 1 year ago

Filed a patent for "broadly neutralizing antibodies against rsv and mpv paramyxoviruses" on Mon, December 5, 2022

New US Patent
vir
over 1 year ago

Filed a patent for "engineered hepatitis b virus neutralizing antibodies and uses thereof" on Thu, August 3, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "high dose antibody therapies for sars-cov-2 infection" on Mon, January 9, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "broadly neutralizing antibodies against rsv and mpv paramyxoviruses" on Tue, January 31, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "predictive universal signatures for multiple disease indications" on Thu, September 7, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "broadly neutralizing antibodies against rsv and mpv paramyxoviruses" on Thu, April 6, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "antibodies and methods for treatment of influenza a infection" on Thu, October 26, 2023

New US Patent
vir
over 1 year ago

Filed a patent for "compositions and methods for treating hepatitis b virus infection" on Thu, March 21, 2024

New US Patent
vir
over 1 year ago

Filed a patent for "machine learning for predicting mutational drivers and likely onset of future pandemics" on Wed, December 20, 2023

New US Patent
Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...